Business Wire

Arthur D. Little Acquires MAG to Expand Media & Telecoms Practice in the US and Globally

13.4.2021 15:48:00 EEST | Business Wire | Press release

Share

Global management consultancy Arthur D. Little (ADL) today announced it has acquired MAG, a US-based management consultancy focused on the convergence of media, technology, and wireless. The deal expands ADL’s global Telecommunications, Information Technology, Media, and Electronics (TIME) Practice and brings additional senior-level expertise to the firm’s growing presence in the US and abroad.

Founded by media and telecoms veterans Shahid Khan, Mark Rowland, George Yun and Fred Boxa, MAG is built around a senior team of seasoned, highly regarded industry experts. The firm brings with it a history of end-to-end engagements spanning from strategy through execution, with a strong reputation for delivering impactful results to some of the world’s leading media brands and communications companies. The team’s expertise addresses critical concerns in the media marketplace through solutions focused on networks and technologies, content and media, and the future of operations.

“The acquisition of MAG is an exciting addition to ADL’s continued expansion in the US market and beyond,” said Craig Wylie, Managing Partner of ADL US. “It follows ADL’s recent partner-level hires in the US Travel and Transportation, and Energy sectors.”

Karim Taga, Managing Partner of ADL Global TIME Practice added, “The MAG team has an extensive track record across the value chain of the media sector, and we know they will provide outstanding senior-level depth to our already strong media and technology capabilities.”

MAG is led by Shahid Khan, a prominent thought leader and serial entrepreneur in the media sector with more than 25 years of experience. The team will work out of ADL’s US offices to service clients in both the US and abroad.

“Our team at MAG is thrilled to join ADL,” said Mr. Khan. “Our culture blends perfectly with ADL’s emphasis on client-focused innovation, execution, and entrepreneurial spirit, while our experience with some of the world’s leading media brands will bring new ideas and opportunities for advances within the industry.”

Ignacio Garcia Alves, Chairman and CEO of ADL, concluded, “As we continue our global growth, we embrace the addition of teams and companies that, like ADL, prioritize innovation and leverage their deep industry expertise to act as ‘breakthrough enablers’, helping our clients to Anticipate, Innovate and Transform. The acquisition of MAG is another important piece of that attractive value proposition.”

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For more information:
Alex DeBlois
Longview Strategies
+1.978.225.9253
adeblois@longviewstrategies.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 02:00:00 EEST | Press release

Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for people living with FOP, bringing a new treatment option to adult and pediatric patients living with this devastating disease,” said Chris Peetz, Chief Executive Officer at Mirum. “At Mirum, we are driven to serve rare disease communities where the unmet need is significant and the opportunity to make a difference is profound. The approval of Atebrioz reflects what can be achieved when industry, researchers

Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 22:19:00 EEST | Press release

At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where Digital Reef will purchase verified environmental assets generated by Oreasoc, supporting the development of low-carbon data centres mitigating their environmental footprint through the protection of high-integrity natural ecosystems across the South American Amazon, whilst advancing sustainable economic development. AI and data centre demand is driving rapid growth, with the International Energy Agency project

NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 16:00:00 EEST | Press release

NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata from data and enables metadata services to scale independently, creating a foundation for AI infrastructure capable of supporting trillions of files, exabyte-scale environments, and massively pa

MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 15:57:00 EEST | Press release

MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity, technology, infrastructure, execution, market access and tailored client solutions within an integrated financial ecosystem. The second award acknowledg

Croma-Pharma Introduces saypha ® volume prime Lidocaine25.9.2026 15:04:00 EEST | Press release

Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine, Croma-Pharma further strengthens its product range, reflecting the company's long-standing commitment to scientific excellence and continuous product innovation, and provid

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye